Interestingly, the average plasma levels of ANXA1 were significantly lower in lipodystrophy patients compared to control (0.2 ± 0.1 ng/mL, n = 9 vs. 0.97 ± 0.1 ng/mL, n = 30, p = 0.008) (Figure 3c). Here, ANXA1 is linked to lipodystrophy.